Effect of Metformin Use on Weight Loss in Obese, Non-diabetic People (MOWRI)

NCT07297290 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

220

Enrollment

NETWORK

Sponsor class

Conditions

Obesity and Cardiovascular Risk
Insulin Resistance
Obesity (Body Mass Index >30 kg/m2)

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

University Of Nigeria Teaching Hospital

Collaborators

[object Object]